Are human CETP mutations and CETP-inhibiting drugs a good or a bad deal?

Tools

Item Type:	Editorial
Title:	Are human CETP mutations and CETP-inhibiting drugs a good or a bad deal?
Creators Name:	Luft, F.C.
Keywords:	Anticholesteremic Agents, Apolipoprotein A-I, Biological Transport, Cholesterol, Cholesterol Ester Transfer Proteins, Coronary Artery Disease, HDL Cholesterol, HDL Lipoproteins, Heterozygote, Hyperlipoproteinemias, LDL Lipoproteins, Liver, Mutation, Randomized Controlled Trials as Topic, Sulfhydryl Compounds, Triglycerides, X-Ray Computed Tomography, Animals
Source:	Journal of Molecular Medicine
ISSN:	0946-2716
Publisher:	Springer
Volume:	84
Page Range:	625-627
Date:	August 2006
Official Publication:	https://doi.org/10.1007/s00109-006-0071-3
PubMed:	View item in PubMed

Repository Staff Only: item control page